Skip to content

JOURNEY II BCS Multi Centre Study in Japan

JOURNEY II BCS Multi Centre Study in Japan - KOOS study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000017124
Enrollment
90
Registered
2015-05-17
Start date
2015-04-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

None listed

Sponsors

International University of Health and Welfare
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Age between 20 years and 75 years Patient belongs to Japanese ethnic group Willing and able to comply with the study Protocol Informed Consent Document (ICD) signed by patient Osteoarthritis in one or more compartments of the knee Non-surgical treatment options have failed to provide relief for symptoms Preoperative radiographic evidence of joint degeneration that cannot be treated in non-operative fashion Knee distal femoral varus deformity between 5 and 30 degrees or distal femur in 5-7 degrees of valgus (normal knee anatomy) Independent of study participation, patient is a candidate for commercially available Journey II BCS Total Knee System in accordance with approved indication

Exclusion criteria

Exclusion criteria: Patients who have an existing medical condition that would, in the opinion of the Investigator, compromise their participation and follow-up in the study No previous or active infection in the affected joint or systemic infection Chronic long acting narcotic pain medication Inflammatory polyarthritis Women who are pregnant Recent history (less than 1 year) of chemical substance dependency or significant psychosocial disturbance that may impact the outcome or study participation, in the opinion of the investigator Participation in a clinical trial of another Investigational Drug or device within the past 30 days Active malignancy or history of invasive malignancy within the last five years, with the exception of superficial basal cell carcinoma or squamous cell carcinoma of the skin that has been definitely treated. Patients with carcinoma in situ of the uterine cervix treated definitely more than 1 year prior to enrollment may enter the study Previous history of infection in the affected joint and/or other local/systemic infection that may affect the prosthetic joint A member of a protected population (e.g., prisoner, mentally incompetent); History of partial or total knee arthroplasty for the ipsilateral knee. History of partial or total hip arthroplasty

Design outcomes

Primary

MeasureTime frame
KOOS-ADL

Countries

Japan

Contacts

Public ContactTakashi Yanagawa

Smith & Nephew Orthopaedics KK Clinical Operations, Research & Engineering

takashi.yanagawa@smith-nephew.com03-5403-8256

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026